Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action
Authors
Keywords
Cell membranes, Lipids, Cholesterol, Membrane potential, Membrane fusion, Fluorescence, HIV-1, Vesicles
Journal
PLoS One
Volume 8, Issue 4, Pages e60302
Publisher
Public Library of Science (PLoS)
Online
2013-04-03
DOI
10.1371/journal.pone.0060302
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesized Peptide Inhibitors of HIV-1 gp41-dependent Membrane Fusion
- (2013) Yuxian He CURRENT PHARMACEUTICAL DESIGN
- Preclinical Evaluation of the HIV-1 Fusion Inhibitor L'644 as a Potential Candidate Microbicide
- (2012) Sarah Harman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Differential Effect of Cholesterol and Its Biosynthetic Precursors on Membrane Dipole Potential
- (2012) Sourav Haldar et al. BIOPHYSICAL JOURNAL
- Microbicides: still a long road to success
- (2012) Christophe Vanpouille et al. TRENDS IN MICROBIOLOGY
- The role of blood cell membrane lipids on the mode of action of HIV-1 fusion inhibitor sifuvirtide
- (2010) Pedro M. Matos et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Quantitative assessment of peptide–lipid interactions.
- (2010) Pedro M. Matos et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and Lymphocyte Membranes
- (2010) Pedro M. Matos et al. PLoS One
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
- (2010) Q. Abdool Karim et al. SCIENCE
- An Albumin-Conjugated Peptide Exhibits Potent Anti-HIV Activity and Long In Vivo Half-Life
- (2009) D. Xie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Peptides in the treatment of AIDS
- (2009) Fred Naider et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions
- (2009) Zoltan Beck et al. PLoS One
- Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency
- (2009) P. Ingallinella et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS Susceptibility
- (2008) Weijing He et al. Cell Host & Microbe
- Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection
- (2008) Sharon S. Lieberman-Blum et al. CLINICAL THERAPEUTICS
- Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
- (2008) Erik De Clercq INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor
- (2008) Cheryl A. Stoddart et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sifuvirtide Screens Rigid Membrane Surfaces. Establishment of a Correlation between Efficacy and Membrane Domain Selectivity among HIV Fusion Inhibitor Peptides
- (2008) Henri G. Franquelim et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Process Development of TRI-999, a Fatty-Acid-Modified HIV Fusion Inhibitory Peptide
- (2007) Huyi Zhang et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started